What is the most recent earnings date for CTXR stock?
CITIUS PHARMACEUTICALS INC (CTXR) last reported earnings on 2/12/2026.
CITIUS PHARMACEUTICALS INC (CTXR) Earnings History & Surprises
NASDAQ:CTXR • US17322U3068
Current stock price
0.8806 USD
-0.08 (-8.48%)
At close:
0.881 USD
+0 (+0.05%)
After Hours:
CTXR Earnings overview
Past quarterly earnings results for CITIUS PHARMACEUTICALS INC (CTXR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 12, 2026
- Period
- Q2 / 2026
- EPS Estimate
- -$0.20
- Revenue Estimate
- 10.068M
Last Reported
Most Recent- Release Date
- Feb 12, 2026
- Period
- Q1 / 2026
- EPS Reported
- EPS Surprise
- %
- Revenue Surprise
- 11.92%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | -0.01 | - | 99.22% | 3.944M | 3.524M | 11.92% | - | |
| Q4 2025 | -0.72 | -0.50 | -45.04% | 54.77% | 5.871M | -100.00% | - | |
| Q3 2025 | -0.80 | -0.60 | -32.93% | 46.67% | 4.405M | -100.00% | - | |
| Q2 2025 | -1.27 | -0.39 | -224.81% | -1.60% | 2.721M | -100.00% | - | |
| Q1 2025 | -1.30 | -0.59 | -121.01% | 13.33% | 7.202M | -100.00% | - | |
| Q4 2024 | -1.59 | -1.53 | -4.05% | 20.40% | - | - | ||
| Q3 2024 | -1.50 | -1.28 | -17.65% | - | - | - | ||
| Q2 2024 | -1.25 | -1.53 | 18.30% | 28.57% | - | - | ||
| Q1 2024 | -1.50 | 3.32 | -145.25% | - | 21.721M | -100.00% | - | |
| Q4 2023 | -2.00 | -0.51 | -292.16% | -60.00% | - | - | ||
| Q3 2023 | -1.50 | -1.40 | -6.95% | - | - | - | ||
| Q2 2023 | -1.75 | -0.89 | -96.08% | -40.00% | - | - | ||
| Q1 2023 | - | - | - | - | ||||
| Q4 2022 | -1.25 | -1.02 | -22.55% | -150.00% | - | - | ||
| Q3 2022 | -1.50 | -1.28 | -17.65% | - | - | - | ||
| Q2 2022 | -1.25 | -1.79 | 29.97% | -25.00% | - | - | ||
| Q1 2022 | -1.50 | -1.53 | 1.96% | 60.00% | - | - | ||
| Q4 2021 | -0.50 | -1.02 | 50.98% | 71.43% | - | - | ||
| Q3 2021 | -1.50 | -1.66 | 9.50% | 45.45% | - | - | ||
| Q2 2021 | -1.00 | -1.91 | 47.71% | 69.23% | - | - | ||
| Q1 2021 | -3.75 | 4.08 | -191.91% | - | 19.154M | -100.00% | - | |
| Q4 2020 | -1.75 | -2.68 | 34.64% | - | - | - | ||
| Q3 2020 | -2.75 | -2.68 | -2.71% | - | - | - | ||
| Q2 2020 | -3.25 | -2.55 | -27.45% | - | - | - | ||
| Q1 2020 | -3.75 | -3.57 | -5.04% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-72.02%
Max Revenue beat (4)
11.92%
Min Revenue beat (4)
-100.00%
Analysis
CTXR has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, CTXR reported -72.0% below the revenue estimates on average.
Related analysis
CITIUS PHARMACEUTICALS INC / CTXR Earnings FAQ
Did CITIUS PHARMACEUTICALS INC (CTXR) beat earnings estimates last quarter?
CITIUS PHARMACEUTICALS INC (CTXR) missed EPS estimates and beat revenue estimates in the most recent quarter.